To further investigate whether these top-ranked metabolites were consistently increased in clinical tumour areas where TGF-β signalling was activated, we analysed the ion intensities of nine PC species in clinical HNSCC tissues. Here, TGFB1 is linked to head and neck squamous cell carcinoma.